Literature DB >> 7782486

Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem.

R Cluydts1, J De Roeck, P Cosyns, P Lacante.   

Abstract

The effects on sleep of two well known hypnotics, lormetazepam and zolpidem, during experimentally induced environmental noise were compared with placebo. In a double-blind, crossover study, 12 normal volunteers were subjected to prerecorded traffic noise with a mean noise level of 52 dB(A) and peaks to 77 dB(A) continuously for 8 hours in bed. Both hypnotics increased total sleep time, predominantly stage 2 sleep. A significant decrease in the number of sleep stage transitions, arousals, and awakenings longer than 3 minutes was found only with lormetazepam. No significant effects on rapid eye movement (REM) and slow wave sleep were observed. Latencies to persistent sleep and REM sleep onset were not different for either active treatment compared with placebo. Only after lormetazepam was performance on the morning reaction time test significantly affected. However, no differences were found in the subjective sleep quality and alertness ratings. Changes in the distribution of sleep stages throughout the night were related to the elimination half-life characteristics of the hypnotics, but few trends were detected. Both the protective properties against environmental noise of the hypnotics studied and the validity of the model of induced sleep disturbance in evaluating hypnotic agents are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782486     DOI: 10.1097/00004714-199504000-00009

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  8 in total

1.  A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers.

Authors:  Louise M Paterson; Sue J Wilson; David J Nutt; Peter H Hutson; Magnus Ivarsson
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 2.  Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

Authors:  K J Holm; K L Goa
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 3.  Zolpidem: a review of its use in the management of insomnia.

Authors:  Tracy Swainston Harrison; Gillian M Keating
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia.

Authors:  Paolo Bettica; Lisa Squassante; John A Groeger; Brian Gennery; Raphaelle Winsky-Sommerer; Derk-Jan Dijk
Journal:  Neuropsychopharmacology       Date:  2012-01-11       Impact factor: 7.853

5.  Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.

Authors:  Barbara M Stone; Claire Turner; Sue L Mills; Isabelle Paty; Alain Patat; Mona Darwish; Philippe Danjou
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

6.  Sleep-promoting properties of quetiapine in healthy subjects.

Authors:  Stefan Cohrs; Andrea Rodenbeck; Zhenghua Guan; Kathrin Pohlmann; Wolfgang Jordan; Andreas Meier; Eckart Rüther
Journal:  Psychopharmacology (Berl)       Date:  2004-03-17       Impact factor: 4.530

Review 7.  Clinical review: The impact of noise on patients' sleep and the effectiveness of noise reduction strategies in intensive care units.

Authors:  Hui Xie; Jian Kang; Gary H Mills
Journal:  Crit Care       Date:  2009-03-09       Impact factor: 9.097

8.  High blood pressure and long-term exposure to indoor noise and air pollution from road traffic.

Authors:  Maria Foraster; Nino Künzli; Inmaculada Aguilera; Marcela Rivera; David Agis; Joan Vila; Laura Bouso; Alexandre Deltell; Jaume Marrugat; Rafel Ramos; Jordi Sunyer; Roberto Elosua; Xavier Basagaña
Journal:  Environ Health Perspect       Date:  2014-07-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.